Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IVERIC bio, Inc. - Common Stock (NQ: ISEE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
From IVERIC bio, Inc.
Via Business Wire
Analyst Ratings for IVERIC bio
IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where IVERIC bio Stands With Analysts
IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript
ISEE earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Iveric Bio Announces Proposed Offering of Common Stock
From IVERIC bio, Inc.
Via Business Wire
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. 
Via Benzinga
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
IVERIC bio: Q3 Earnings Insights
IVERIC bio (NASDAQ:ISEE) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. 
Via Benzinga
Nasdaq Down 0.5%; Clearfield Shares Spike Higher
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday. 
Via Benzinga
Why Is Iveric Bio (ISEE) Stock Up 25% Today?
Biotechnology firm Iveric Bio shot up on a regulatory green light for its key therapeutic, sparking interest in high-risker play ISEE stock. 
Via InvestorPlace
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks Brushing Off Latest Fed Fears
The Dow Jones Industrial Average is up triple digits midday, while the S&P 500 Index and Nasdaq Composite sit hesitantly higher. 
Via Talk Markets
Nasdaq Turns Lower; Crude Oil Down Over 3%
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday. 
Via Benzinga
Dow Surges Over 100 Points; Foot Locker Earnings Top Views
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. 
Via Benzinga
Apellis Pharmaceuticals Surges On New Review Date For Eye-Disease Treatment
The delay is at Apellis' behest. The company wanted to include updated data in its request. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start closing out the trading week with a dive into the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
IVERIC bio Secures Breakthrough Therapy Tag For Its Flagship Geographic Atrophy Candidate
Via Benzinga
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Upgrades 
Via Benzinga
Iveric Bio to Present at Upcoming Investor Conferences
From Iveric Bio
Via Business Wire
Apellis Pharma Crashes On Unexpected Delay For Eye Drug — A Boon For Iveric Bio
Apellis long said it wouldn't wait for 24-month data for its eye drug. Apellis was wrong. 
Via Investor's Business Daily
Iveric Bio Announces Submission of First Part of NDA for Rolling Review of Avacincaptad Pegol for the Treatment of Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.